4.8 Article

Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 127, Issue 5, Pages 1918-1931

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI91406

Keywords

-

Funding

  1. Japan Society for the Promotion of Science (JSPS) KAKENHI [16H05337]
  2. Dainippon Sumitomo Pharma Co., Ltd.
  3. Grants-in-Aid for Scientific Research [15K09478, 16H05337, 17H05649, 15H01513] Funding Source: KAKEN

Ask authors/readers for more resources

The eleven-nineteen leukemia (ENL) protein family, composed of ENL and AF9, is a common component of 3 transcriptional modulators: AF4-ENL-P-TEFb complex (AEP), DOT1L-AF10-ENL complex (referred to as the DOT1L complex) and polycomb-repressive complex 1 (PRC1). Each complex associates with chromatin via distinct mechanisms, conferring different transcriptional properties including activation, maintenance, and repression. The mixed-lineage leukemia (MLL) gene often fuses with ENL and AF10 family genes in leukemia. However, the functional interrelationship among those 3 complexes in leukemic transformation remains largely elusive. Here, we have shown that MLL-ENL and MLL-AF10 constitutively activate transcription by aberrantly inducing both AEP-dependent transcriptional activation and DOT1L-dependent transcriptional maintenance, mostly in the absence of PRC1, to fully transform hematopoietic progenitors. These results reveal a cooperative transcriptional activation mechanism of AEP and DOT1L and suggest a molecular rationale for the simultaneous inhibition of the MLL fusion-AF4 complex and DOT1L for more effective treatment of MLL-rearranged leukemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available